Roivant Financial Statements From 2010 to 2025
| ROIVWDelisted Stock | USD 2.68 0.36 11.84% |
Check Roivant Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Roivant Sciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Roivant financial statements analysis is a perfect complement when working with Roivant Sciences Valuation or Volatility modules.
Roivant |
Roivant Sciences Company Operating Margin Analysis
Roivant Sciences' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Roivant Sciences Operating Margin | (37.08) % |
Most of Roivant Sciences' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Roivant Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Roivant Sciences has an Operating Margin of -37.0846%. This is 5.71% higher than that of the Biotechnology sector and 66.91% lower than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.
Roivant Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Roivant Sciences's current stock value. Our valuation model uses many indicators to compare Roivant Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Roivant Sciences competition to find correlations between indicators driving Roivant Sciences's intrinsic value. More Info.Roivant Sciences is currently regarded as top stock in operating margin category among its peers. It is rated second in number of shares shorted category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Roivant Sciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Roivant Sciences Financial Statements
Roivant Sciences investors use historical fundamental indicators, such as Roivant Sciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Roivant Sciences. Please read more on our technical analysis and fundamental analysis pages.
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company was founded in 2014 and is based in London, the United Kingdom. Roivant Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 620 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Roivant Stock
If you are still planning to invest in Roivant Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Roivant Sciences' history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |